News Preview
MaxCyte, Inc. (MXCT) Q3 2026 Earnings Call Transcript
MaxCyte, Inc. (MXCT) announced Q3 2026 financial results, with revenue and EPS exceeding analyst estimates.
The company's CEO provided an update on clinical trials and commercial progress.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.